
Envision Research Institute Publishes Study In PLOS One, Advancing Independence For People With Vision Loss
Dr. Sarika Gopalakrishnan evaluated three different models of augmented reality (AR) devices, Ziru, IrisVision, and NuEyes, to determine which provides the best visual enhancement for people with low vision and found that two of them, Ziru and IrisVision, delivered meaningful improvements in vision-related tasks, while NuEyes showed limited benefits.
“Living with low vision is a daily challenge that touches every visual task,” said Dr. Sarika Gopalakrishnan, research program manager at ERI.“This research is not just about technology, it's about identifying which tools truly help people regain confidence, independence, and motivation in daily life.”
“This research is crucial because it provides clear, evidence-based insights into which technologies offer the most meaningful improvements for people with low vision,” said Lou Celli, executive director of ERI.“By identifying practical tools that truly enhance independence and quality of life, Envision can better guide clinicians, patients, and stakeholders toward solutions that make a real difference."
More than 285 million people worldwide live with low vision, underscoring the potential impact of these findings. The results not only show how today's devices support daily life but also lay groundwork for future healthcare approaches and innovation in assistive technology.
By appearing in PLOS One, ERI's research is freely available worldwide, creating visibility, credibility, and momentum for future breakthroughs that change lives.
About Envision: Envision promotes advocacy and independence for those who are blind or low vision. Founded in 1933, Envision is one of the largest employers of individuals with vision loss in the nation. Headquartered in Wichita, Kan., Envision's mission is to improve the quality of life and provide inspiration and opportunity for people who are blind or visually impaired through employment, outreach, rehabilitation, education and research. For more information, visit
About PLOS O ne
PLOS One is a peer-reviewed, open-access scientific journal that publishes original research across all areas of science and medicine. As part of the Public Library of Science (PLOS), it is one of the most widely read multidisciplinary journals in the world. All articles are freely available online, making research immediately visible and citable by scientists, educators, policymakers, and practitioners worldwide.
Attachments
-
Demonstrating an augmented reality headset for low vision
Wearable augmented reality devices evaluated in the study


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Pepeto Presale Exceeds $6.93 Million Staking And Exchange Demo Released
- Citadel Launches Suiball, The First Sui-Native Hardware Wallet
- Luminadata Unveils GAAP & SOX-Trained AI Agents Achieving 99.8% Reconciliation Accuracy
- Tradesta Becomes The First Perpetuals Exchange To Launch Equities On Avalanche
- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
Comments
No comment